{"id":35159,"date":"2026-02-10T15:35:03","date_gmt":"2026-02-10T15:35:03","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/gene-vector-market-mordor\/"},"modified":"2026-10-02T03:25:40","modified_gmt":"2026-10-01T18:25:40","slug":"gene-vector-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/gene-vector-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uc720\uc804\uc790 \ubca1\ud130 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026-2031\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/gene-vector-market-1752058971653-major-players.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/gene-vector-market-size-image-1768489938356.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uc720\uc804\uc790 \uce58\ub8cc \ud30c\uc774\ud504\ub77c\uc778 \ud655\uc7a5 \ubc0f \uc2b9\uc778<\/li>\n<li class=\"toc-level-3\">4.2.2 \uc804\ub7b5\uc801 \ud611\ub825 \ubc0f CDMO \uc0dd\uc0b0 \ub2a5\ub825 \ud655\uc7a5<\/li>\n<li class=\"toc-level-3\">4.2.3 \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uc0dd\uc0b0 \uae30\uc220\uc758 \ubc1c\uc804<\/li>\n<li class=\"toc-level-3\">4.2.4 \ube44\ubc14\uc774\ub7ec\uc2a4 \uc804\ub2ec \ud50c\ub7ab\ud3fc\uc5d0 \ub300\ud55c \ud22c\uc790 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.5 \ud76c\uadc0 \uc9c8\ud658 \uce58\ub8cc\ub97c \uc704\ud55c \uc815\ubd80 \uc790\uae08 \uc9c0\uc6d0<\/li>\n<li class=\"toc-level-3\">4.2.6 \uc0c8\ub85c\uc6b4 \ud604\uc7a5 \uc9c4\ub8cc \uc81c\uc870 \ubaa8\ub378<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \ub192\uc740 \uc81c\uc870 \ube44\uc6a9 \ubc0f \uacf5\uc815 \ubcf5\uc7a1\uc131<\/li>\n<li class=\"toc-level-3\">4.3.2 \uc219\ub828\ub41c \uc778\ub825 \ubd80\uc871 \ubc0f \uad50\uc721 \uaca9\ucc28<\/li>\n<li class=\"toc-level-3\">4.3.3 \uc911\uc694 \uc6d0\uc790\uc7ac \uacf5\uae09\ub9dd \uc81c\uc57d<\/li>\n<li class=\"toc-level-3\">4.3.4 \uc2e0\uaddc \ucea1\uc2dc\ub4dc\uc758 \uc9c0\uc801 \uc7ac\uc0b0\uad8c \uc7a5\ubcbd<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.5 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.5.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.5.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.5.3 \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.5.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.5.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (\uac00\uce58 \ubc0f \ubb3c\ub7c9)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \ubca1\ud130 \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130<\/li>\n<li class=\"toc-level-4\">5.1.1.1 \uc544\ub370\ub178-\uc5f0\uad00 \ubc14\uc774\ub7ec\uc2a4 (AAV)<\/li>\n<li class=\"toc-level-4\">5.1.1.2 \ub80c\ud2f0\ubc14\uc774\ub7ec\uc2a4<\/li>\n<li class=\"toc-level-4\">5.1.1.3 \uc544\ub370\ub178\ubc14\uc774\ub7ec\uc2a4<\/li>\n<li class=\"toc-level-4\">5.1.1.4 \ub808\ud2b8\ub85c\ubc14\uc774\ub7ec\uc2a4 \/ \uac10\ub9c8\ub808\ud2b8\ub85c\ubc14\uc774\ub7ec\uc2a4<\/li>\n<li class=\"toc-level-4\">5.1.1.5 \ud5e4\ub974\ud398\uc2a4 \uc2ec\ud50c\ub809\uc2a4 \ubc14\uc774\ub7ec\uc2a4<\/li>\n<li class=\"toc-level-3\">5.1.2 \ube44\ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130<\/li>\n<li class=\"toc-level-4\">5.1.2.1 \ud50c\ub77c\uc2a4\ubbf8\ub4dc DNA<\/li>\n<li class=\"toc-level-4\">5.1.2.2 \uc9c0\uc9c8 \ub098\ub178\uc785\uc790 (LNP)<\/li>\n<li class=\"toc-level-4\">5.1.2.3 \uace0\ubd84\uc790 \uae30\ubc18 \ubca1\ud130<\/li>\n<li class=\"toc-level-4\">5.1.2.4 \ud558\uc774\ube0c\ub9ac\ub4dc \ubca1\ud130<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uc804\ub2ec \ubc29\ubc95\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \uc0dd\uccb4 \ub0b4 \uc720\uc804\uc790 \uc804\ub2ec<\/li>\n<li class=\"toc-level-3\">5.2.2 \uc0dd\uccb4 \uc678 \uc720\uc804\uc790 \uc804\ub2ec<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \uce58\ub8cc \ubd84\uc57c\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \uc885\uc591\ud559<\/li>\n<li class=\"toc-level-3\">5.3.2 \uc720\uc804 \uc9c8\ud658<\/li>\n<li class=\"toc-level-3\">5.3.3 \uac10\uc5fc\uc131 \uc9c8\ud658<\/li>\n<li class=\"toc-level-3\">5.3.4 \uc2ec\ud608\uad00 \uc9c8\ud658<\/li>\n<li class=\"toc-level-3\">5.3.5 \uc548\uacfc<\/li>\n<li class=\"toc-level-3\">5.3.6 \uc2e0\uacbd \uc9c8\ud658<\/li>\n<li class=\"toc-level-3\">5.3.7 \uae30\ud0c0<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \ubc14\uc774\uc624\uc81c\uc57d &amp; \uc0dd\uba85\uacf5\ud559 \uae30\uc5c5<\/li>\n<li class=\"toc-level-3\">5.4.2 \uc704\ud0c1 \uac1c\ubc1c &amp; \uc81c\uc870 \uc870\uc9c1 (CDMO)<\/li>\n<li class=\"toc-level-3\">5.4.3 \ud559\uc220 &amp; \uc5f0\uad6c \uae30\uad00<\/li>\n<li class=\"toc-level-3\">5.4.4 \ubcd1\uc6d0 &amp; \ud074\ub9ac\ub2c9<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \uc0dd\uc0b0 \uc6cc\ud06c\ud50c\ub85c\uc6b0\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \uc5c5\uc2a4\ud2b8\ub9bc \uacf5\uc815<\/li>\n<li class=\"toc-level-3\">5.5.2 \ub2e4\uc6b4\uc2a4\ud2b8\ub9bc \uacf5\uc815<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.6 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.6.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.6.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.6.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.6.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.6.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.6.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.6.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.6.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.6.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.6.3 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.6.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.6.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.6.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.6.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.6.4 \uc911\ub3d9 &amp; \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.6.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.6.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.6.4.3 \uae30\ud0c0 \uc911\ub3d9 &amp; \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.6.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.6.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.6.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.6.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uac1c\uc694, \ud575\uc2ec \uc0ac\uc5c5 \ubd80\ubb38, \uc7ac\ubb34, \uc778\ub825, \uc8fc\uc694 \uc815\ubcf4, \uc2dc\uc7a5 \uc21c\uc704, \uc2dc\uc7a5 \uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uc2e0 \uac1c\ubc1c \ubd84\uc11d \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 Thermo Fisher Scientific, Inc.<\/li>\n<li class=\"toc-level-3\">6.3.2 Merck KGaA (MilliporeSigma)<\/li>\n<li class=\"toc-level-3\">6.3.3 Lonza Group<\/li>\n<li class=\"toc-level-3\">6.3.4 Catalent Inc.<\/li>\n<li class=\"toc-level-3\">6.3.5 Oxford Biomedica<\/li>\n<li class=\"toc-level-3\">6.3.6 Aldevron (Danaher)<\/li>\n<li class=\"toc-level-3\">6.3.7 Charles River Laboratories<\/li>\n<li class=\"toc-level-3\">6.3.8 WuXi AppTec \/ WuXi Advanced Therapies<\/li>\n<li class=\"toc-level-3\">6.3.9 Samsung Biologics<\/li>\n<li class=\"toc-level-3\">6.3.10 Genezen<\/li>\n<li class=\"toc-level-3\">6.3.11 Viralgen Vector Core<\/li>\n<li class=\"toc-level-3\">6.3.12 Novartis AG<\/li>\n<li class=\"toc-level-3\">6.3.13 Pfizer Inc.<\/li>\n<li class=\"toc-level-3\">6.3.14 uniQure N.V.<\/li>\n<li class=\"toc-level-3\">6.3.15 Bluebird Bio<\/li>\n<li class=\"toc-level-3\">6.3.16 4D Molecular Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.17 VGXI Inc.<\/li>\n<li class=\"toc-level-3\">6.3.18 Avid Bioservices<\/li>\n<li class=\"toc-level-3\">6.3.19 Biomarin Pharmaceutical<\/li>\n<li class=\"toc-level-3\">6.3.20 Takara Bio<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c &amp; \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uc720\uc804\uc790 \ubca1\ud130 \uc2dc\uc7a5 \uac1c\uc694 (2026-2031)<\/p>\n<p>\uc720\uc804\uc790 \ubca1\ud130 \uc2dc\uc7a5\uc740 \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uce58\ub8cc\uc81c\uc758 \uc0c1\uc5c5\ud654\uac00 \uac00\uc18d\ud654\ub428\uc5d0 \ub530\ub77c 2026\ub144 21\uc5b5 2\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0\uc11c 2031\ub144 37\uc5b5 9\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \uc608\uce21 \uae30\uac04 \ub3d9\uc548 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 12.29%\ub97c \uae30\ub85d\ud560 \uc804\ub9dd\uc785\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc131\uc7a5\uc740 2024\ub144\uc5d0\ub9cc 7\uac74\uc758 \uc2e0\uaddc \uc2b9\uc778\uc774 \uc774\ub8e8\uc5b4\uc9c0\ub294 \ub4f1 \uaddc\uc81c \uae30\uad00\uc758 \uc2e0\uc18d\ud55c \uc2b9\uc778\uacfc \ud654\uc774\uc790(Pfizer)\uc758 \ud608\uc6b0\ubcd1 B \uce58\ub8cc\uc81c BEQVEZ, \uc774\uc624\ubc18\uc2a4 \ubc14\uc774\uc624\ud14c\ub77c\ud4e8\ud2f1\uc2a4(Iovance Biotherapeutics)\uc758 \ud751\uc0c9\uc885 \uce58\ub8cc\uc81c AMTGVI\uc640 \uac19\uc740 \uc8fc\uc694 \uc81c\ud488 \uc2b9\uc778\uc5d0 \ud798\uc785\uc740 \ubc14 \ud07d\ub2c8\ub2e4.<\/p>\n<p>\ud604\uc7ac \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130\uac00 \uc2dc\uc7a5\uc744 \uc9c0\ubc30\ud558\uace0 \uc788\uc9c0\ub9cc, \ube44\ubc14\uc774\ub7ec\uc2a4 \uc2dc\uc2a4\ud15c\uc740 \uc0b0\uc5c5 \uaddc\ubaa8\uc758 \ubc14\uc774\uc624 \uc81c\uc870\uc5d0 \ub354 \uc801\ud569\ud55c \uc0dd\uc0b0 \ubc29\uc2dd\uc73c\ub85c \uc778\ud574 \ud22c\uc790\uac00 \uc99d\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub610\ud55c, \uc544\uc6c3\uc18c\uc2f1 \ucd94\uc138\uac00 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uacac\uc778\ud558\uc5ec 2024\ub144\uc5d0\ub294 \uacc4\uc57d \uac1c\ubc1c \ubc0f \uc81c\uc870 \uc870\uc9c1(CDMO)\uc774 \uc804\uccb4 \ucd5c\uc885 \uc0ac\uc6a9\uc790 \ub9e4\ucd9c\uc758 \uc808\ubc18 \uc774\uc0c1\uc744 \ucc28\uc9c0\ud588\uc73c\uba70, \uc774\ub4e4\uc740 \uc2e0\uaddc \uc0dd\uc0b0 \ub2a5\ub825\uc5d0 \ub300\ud55c \ud22c\uc790\ub97c \uc9c0\uc18d\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30\ub825<\/p>\n<p>1. \uc2dc\uc7a5 \uc131\uc7a5 \ub3d9\ub825:<\/p>\n<p>*   \uc720\uc804\uc790 \uce58\ub8cc\uc81c \ud30c\uc774\ud504\ub77c\uc778 \ud655\uc7a5 \ubc0f \uc2b9\uc778 \uc99d\uac00 (CAGR\uc5d0 +2.8% \uc601\ud5a5): 2024\ub144 7\uac74\uc758 \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uc81c\ud488 \uc2b9\uc778\uc740 \uc5ed\uc0ac\uc801 \uc18d\ub3c4\uc758 3\ubc30\uc5d0 \ub2ec\ud558\uba70, FDA\ub294 2025\ub144\ubd80\ud130 \ub9e4\ub144 10~20\uac74\uc758 \uc2b9\uc778\uc744 \uc608\uc0c1\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc804 \uc138\uacc4\uc801\uc73c\ub85c 900\uac1c \uc774\uc0c1\uc758 \uc784\uc0c1 \uc2dc\ud5d8\uc774 \uc9c4\ud589 \uc911\uc774\uba70, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc758 \uc784\uc0c1 \uc2dc\ud5d8 \uaddc\ubaa8\ub294 \ubd81\ubbf8\uc640 \uc720\ub7fd\uc744 \ud569\uce5c \uc218\uc900\uc5d0 \uc774\ub974\uace0 \uc788\uc2b5\ub2c8\ub2e4. 2023\ub144 \ubc14\uc774\uc624\ud14d \uc2dc\uc7a5\uc758 \uc5ed\ud48d\uc5d0\ub3c4 \ubd88\uad6c\ud558\uace0 \ubca4\ucc98 \ud380\ub4dc\ub294 \uac1c\ubc1c\uc0ac\uc5d0 34\uc5b5 \ub2ec\ub7ec\ub97c \ud22c\uc790\ud588\uc73c\uba70, \ud76c\uadc0\uc758\uc57d\ud488 \uc9c0\uc815\uc740 \uc2dc\uc7a5 \ucd9c\uc2dc\ub97c \uac00\uc18d\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc804\ub7b5\uc801 \ud611\ub825 \ubc0f CDMO \uc0dd\uc0b0 \ub2a5\ub825 \ud655\uc7a5 (CAGR\uc5d0 +1.5% \uc601\ud5a5): 2023\ub144 \uc774\ud6c4 \uc804\ubb38 \uc81c\uc870\uc5c5\uccb4\ub4e4\uc740 20\uc5b5 \ub2ec\ub7ec \uc774\uc0c1\uc758 \uc2e0\uaddc \uc0dd\uc0b0 \ub2a5\ub825 \ud655\uc7a5\uc744 \ubc1c\ud45c\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub294 \ub300\ubd80\ubd84\uc758 \uc2a4\ud3f0\uc11c\uac00 \ub0b4\ubd80 \uc790\uc6d0\uc73c\ub85c \uac10\ub2f9\ud558\uae30 \uc5b4\ub824\uc6b4 \uae30\uc220\uc801 \ub09c\uc774\ub3c4(\ud2b9\ud788 \uc544\ub370\ub178 \uad00\ub828 \ubc0f \ub80c\ud2f0\ubc14\uc774\ub7ec\uc2a4 \uc2dc\uc2a4\ud15c)\ub85c \uc778\ud574 \uc544\uc6c3\uc18c\uc2f1\uc774 \uc99d\uac00\ud558\uace0 \uc788\uc74c\uc744 \ubc18\uc601\ud569\ub2c8\ub2e4. CDMO\ub4e4\uc740 \ub2e4\ub144\uac04\uc758 \uacc4\uc57d\uc744 \ud1b5\ud574 \ud65c\uc6a9 \uc704\ud5d8\uc744 \uad00\ub9ac\ud558\uace0 \uc788\uc73c\uba70, \ub178\ubcf4 \ud640\ub529\uc2a4(Novo Holdings)\uc758 \uce74\ud0c8\ub80c\ud2b8(Catalent) \uc778\uc218\uc640 \uac19\uc740 \ud1b5\ud569\uc740 \uc81c\uc870 \uc804\ubb38\uc131\uc744 \uc9d1\uc911\uc2dc\ud0a4\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uc0dd\uc0b0 \uae30\uc220 \ubc1c\uc804 (CAGR\uc5d0 +1.2% \uc601\ud5a5): \uba38\uc2e0\ub7ec\ub2dd \ub3c4\uad6c\ub294 \ucea1\uc2dc\ub4dc \uc124\uacc4 \ubc18\ubcf5 \uc8fc\uae30\ub97c \uc218\ub144\uc5d0\uc11c \uc218\uac1c\uc6d4\ub85c \ub2e8\ucd95\uc2dc\ud0a4\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud39c\uc2e4\ubca0\uc774\ub2c8\uc544 \ub300\ud559\uad50\ub294 \uace0\uc804\uc801\uc778 AAV \uc2dc\uc2a4\ud15c\uc744 \ubcf4\uc644\ud558\uace0 \uaddc\ubaa8 \uc81c\ud55c\uc744 \uc6b0\ud68c\ud560 \uc218 \uc788\ub294 \uc9c0\uc9c8 \uae30\ubc18 DNA \uc6b4\ubc18\uccb4\ub97c \uc2dc\uc5f0\ud588\uc2b5\ub2c8\ub2e4. FDA\ub294 \ubd84\uc0b0\ud615 CAR-T \uc81c\uc870\ub97c \uc2b9\uc778\ud558\uc5ec \uce58\ub8cc \uc13c\ud130 \uadfc\ucc98\uc5d0 \uc18c\uaddc\ubaa8\uc758 \uc720\uc5f0\ud55c \uc2dc\uc124\uc744 \uac00\ub2a5\ud558\uac8c \ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uae30\uc220 \ubc1c\uc804\uc740 \ud604\uc7ac 100\ub9cc \ub2ec\ub7ec\ub97c \ucd08\uacfc\ud558\ub294 \ud3c9\uade0 \ud22c\uc5ec\ub7c9 \ube44\uc6a9\uc744 \uc808\uac10\ud558\ub294 \uac83\uc744 \ubaa9\ud45c\ub85c \ud569\ub2c8\ub2e4.<br \/>\n*   \ube44\ubc14\uc774\ub7ec\uc2a4 \uc804\ub2ec \ud50c\ub7ab\ud3fc\uc5d0 \ub300\ud55c \ud22c\uc790 \uc99d\uac00 (CAGR\uc5d0 +0.9% \uc601\ud5a5): \ud22c\uc790\uc790\ub4e4\uc740 \ube44\ubc14\uc774\ub7ec\uc2a4 \uc2a4\ud0c0\ud2b8\uc5c5\uc744 \uc9c0\uc6d0\ud558\ub294\ub370, \uc774\ub294 \ud569\uc131 \uc6b4\ubc18\uccb4\uac00 \ubc14\uc774\ub7ec\uc2a4 \uc2dc\uc2a4\ud15c\uc758 \uacf5\uae09 \uc81c\ud55c \ubc0f \ud2b9\ud5c8 \ubb38\uc81c\ub97c \ud68c\ud53c\ud560 \uc218 \uc788\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4. mRNA \ubc31\uc2e0\uc5d0\uc11c \uc785\uc99d\ub41c \uc9c0\uc9c8 \ub098\ub178\uc785\uc790\ub294 \ud45c\uc900 \ubb34\uade0 \ucda9\uc804-\ub9c8\uac10 \uacf5\uc7a5\uc5d0\uc11c \uc218\uc2ed\uc5b5 \ub3c4\uc988 \uaddc\ubaa8\ub85c \uc81c\uc870\ub420 \uc218 \uc788\uc5b4 \uc2dc\uc7a5\uc744 \ud655\ub300\ud569\ub2c8\ub2e4. REGENXBIO-\uc0ac\ub819\ud0c0(Sarepta) \ud2b9\ud5c8 \uc18c\uc1a1\uc740 \uac1c\ubc1c\uc790\ub4e4\uc774 \ube44\ubc14\uc774\ub7ec\uc2a4 \ubd84\uc57c\uc758 \uac1c\ubc29\ud615 IP \uacf5\uac04\uc73c\ub85c \uc774\ub3d9\ud558\ub3c4\ub85d \uc720\ub3c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ud76c\uadc0 \uc9c8\ud658 \uce58\ub8cc\ub97c \uc704\ud55c \uc815\ubd80 \uc790\uae08 \uc9c0\uc6d0 (CAGR\uc5d0 +0.7% \uc601\ud5a5): \uc8fc\ub85c \ubd81\ubbf8\uc640 \uc720\ub7fd\uc5d0\uc11c \ud65c\ubc1c\ud569\ub2c8\ub2e4.<br \/>\n*   \uc0c8\ub85c\uc6b4 \ud604\uc7a5 \uc81c\uc870 \ubaa8\ub378 (CAGR\uc5d0 +0.4% \uc601\ud5a5): \ubd81\ubbf8\uc640 \uc720\ub7fd\uc5d0\uc11c \ucd08\uae30 \ub3c4\uc785\uc774 \uc774\ub8e8\uc5b4\uc9c0\uace0 \uc788\uc73c\uba70, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc5d0\uc11c\ub3c4 \ucc44\ud0dd\uc774 \uc2dc\uc791\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>2. \uc2dc\uc7a5 \uc131\uc7a5 \uc800\ud574 \uc694\uc778:<\/p>\n<p>*   \ub192\uc740 \uc81c\uc870 \ube44\uc6a9 \ubc0f \uacf5\uc815 \ubcf5\uc7a1\uc131 (CAGR\uc5d0 -1.2% \uc601\ud5a5): \ub9ce\uc740 \uce58\ub8cc\uc81c\uac00 \ud658\uc790\ub2f9 100\ub9cc \ub2ec\ub7ec \uc774\uc0c1\uc744 \ud638\uac00\ud558\uba70, \uc0dd\ubb3c \ubc18\uc751\uae30, \ud50c\ub77c\uc2a4\ubbf8\ub4dc \uacf5\uae09, \ubb34\uade0 \ucda9\uc804 \ub2e8\uacc4\ub294 \uc5ec\uc804\ud788 \ub178\ub3d9 \uc9d1\uc57d\uc801\uc785\ub2c8\ub2e4. CDMO\uc758 80%\uac00 2022\ub144 \uc774\ud6c4 \uac00\uaca9\uc744 \uc778\uc0c1\ud588\uc9c0\ub9cc, \uacbd\uc7c1\uc801\uc778 \uc785\ucc30 \ud658\uacbd\uc5d0\uc11c \ub9c8\uc9c4 \uac1c\uc120\uc740 \uc5b4\ub835\uc2b5\ub2c8\ub2e4. \uc368\ubaa8 \ud53c\uc154(Thermo Fisher)\uc758 \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uc0ac\uc5c5 \ucca0\uc218\ub294 \ube44\uc6a9 \uc555\ubc15\uc774 \ub300\uae30\uc5c5\uc5d0\ub3c4 \uc601\ud5a5\uc744 \ubbf8\uce60 \uc218 \uc788\uc74c\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4.<br \/>\n*   \ud575\uc2ec \uc6d0\uc790\uc7ac \uacf5\uae09\ub9dd \uc81c\uc57d (CAGR\uc5d0 -0.8% \uc601\ud5a5): \ubca1\ud130 \ub4f1\uae09 API \uacf5\uae09\uc5c5\uccb4\uc758 75%\uac00 \ubbf8\uad6d \uc678 \uc9c0\uc5ed\uc5d0 \uc788\uc5b4 \uc9c0\uc815\ud559\uc801 \ubc0f \ubb3c\ub958 \uc704\ud5d8\uc5d0 \ub178\ucd9c\ub418\uc5b4 \uc788\uc2b5\ub2c8\ub2e4. 2024\ub144 \ub80c\ud2f0\ubc14\uc774\ub7ec\uc2a4 \ubd80\uc871\uc740 CAR-T \uc0dd\uc0b0\uc5d0 \ucc28\uc9c8\uc744 \ube5a\uc5b4 \ud658\uc790 \uce58\ub8cc \uc9c0\uc5f0\uc744 \ucd08\ub798\ud588\uc2b5\ub2c8\ub2e4. \ub3d9\ubb3c \uc720\ub798 \ubc30\uc9c0 \uc131\ubd84\uc5d0 \ub300\ud55c \uaddc\uc81c \uac15\ud654\ub294 \uc0dd\uc0b0 \uc18d\ub3c4\ub97c \ub2a6\ucd94\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc219\ub828\ub41c \uc778\ub825 \ubd80\uc871 \ubc0f \uad50\uc721 \uaca9\ucc28 (CAGR\uc5d0 -0.6% \uc601\ud5a5): \uc804 \uc138\uacc4\uc801\uc73c\ub85c, \ud2b9\ud788 \ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc5d0\uc11c \ub450\ub4dc\ub7ec\uc9d1\ub2c8\ub2e4.<br \/>\n*   \uc2e0\uaddc \ucea1\uc2dc\ub4dc \ubd84\uc57c\uc758 \uc9c0\uc801 \uc7ac\uc0b0\uad8c \uc7a5\ubcbd (CAGR\uc5d0 -0.5% \uc601\ud5a5): \ubd81\ubbf8\uc640 \uc720\ub7fd\uc774 \uc8fc\ub3c4\ud558\uba70, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc5d0\uc11c\ub3c4 \ubd80\uc0c1\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc138\uadf8\uba3c\ud2b8 \ubd84\uc11d<\/p>\n<p>*   \ubca1\ud130 \uc720\ud615: \ubc14\uc774\ub7ec\uc2a4 \ud50c\ub7ab\ud3fc\uc740 2025\ub144 \ub9e4\ucd9c\uc758 72.10%\ub97c \ucc28\uc9c0\ud558\uba70 \uc2dc\uc7a5\uc744 \uc8fc\ub3c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc544\ub370\ub178 \uad00\ub828 \ubc14\uc774\ub7ec\uc2a4(AAV)\ub294 \uc6b0\uc218\ud55c \uc548\uc804\uc131 \ud504\ub85c\ud30c\uc77c\ub85c \uc778\ud574 \uc5ec\uc804\ud788 \ud575\uc2ec\uc801\uc778 \uc5ed\ud560\uc744 \ud558\uc9c0\ub9cc, \ucd5c\uadfc \uc124\uce58\ub958\uc5d0\uc11c \uc0bd\uc785 \ub3cc\uc5f0\ubcc0\uc774 \uc720\ubc1c \ubcf4\uace0\ub85c \uc778\ud574 \ud1b5\ud569 \uc774\ubca4\ud2b8\uc5d0 \ub300\ud55c \uc2ec\uce35 \uac80\ud1a0\uac00 \uc774\ub8e8\uc5b4\uc9c0\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ube44\ubc14\uc774\ub7ec\uc2a4 \uc6b4\ubc18\uccb4\ub294 14.38%\uc758 CAGR\ub85c \ube60\ub974\uac8c \uc131\uc7a5\ud558\uace0 \uc788\uc73c\uba70, \ud569\uc131 \ud654\ud559 \ubc0f \uc9c0\uc9c8 \uc81c\ud615\uc774 \ucc28\uc138\ub300 \uc0dd\uc0b0\uc131 \ub3d9\ub825\uc73c\ub85c \ubd80\uc0c1\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ube44\ubc14\uc774\ub7ec\uc2a4 \ubc29\uc2dd\uc740 \ub354 \uac04\ub2e8\ud55c \ubb34\uade0 \uc5ec\uacfc, \ubcf5\uc81c \uac00\ub2a5\ud55c \ubc14\uc774\ub7ec\uc2a4 \ud14c\uc2a4\ud2b8 \ubd88\ud544\uc694, \uc138\ud3ec \ubc30\uc591 \ud68c\ud53c \ub4f1\uc758 \uc774\uc810\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<br \/>\n*   \uc804\ub2ec \ubc29\uc2dd: \uc0dd\uccb4 \ub0b4(In-vivo) \ud22c\uc5ec\ub294 2025\ub144 59.95%\uc758 \uc810\uc720\uc728\uc744 \uae30\ub85d\ud558\uba70 LUXTURNA \ubc0f ZOLGENSMA\uc640 \uac19\uc740 \ube14\ub85d\ubc84\uc2a4\ud130 \uc81c\ud488\uc5d0 \ud798\uc785\uc5b4 \uc2dc\uc7a5\uc744 \uc120\ub3c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \uc0dd\uccb4 \uc678(Ex-vivo) \uc138\ud3ec \ud3b8\uc9d1\uc740 15.21%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub294 \ubd84\uc0b0\ud615 \uc2dc\uc124\uc744 \ud1b5\ud574 \ubcd1\uc6d0\uc5d0\uc11c \uc790\uac00 \uc138\ud3ec\ub97c \uad6d\uacbd \uac04 \uc6b4\uc1a1 \uc5c6\uc774 \uc870\uc791\ud560 \uc218 \uc788\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4. \ucf5c\ub4dc\uccb4\uc778 \uc2a4\ud2b8\ub808\uc2a4\uc640 AAV \uc548\uc804\uc131 \uacbd\uace0\ub294 \uc7ac\uc8fc\uc785 \uc804 \ud488\uc9c8\uc744 \ud655\uc778\ud560 \uc218 \uc788\ub294 \uc0dd\uccb4 \uc678 \ubc29\uc2dd\uc5d0 \ub300\ud55c \uad00\uc2ec\uc744 \ub192\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uce58\ub8cc \ubd84\uc57c: \uc885\uc591\ud559\uc740 2025\ub144 \ub9e4\ucd9c\uc758 41.12%\ub97c \ucc28\uc9c0\ud558\uba70 CAR-T \ubc0f \uc885\uc591 \uce68\uc724 \ub9bc\ud504\uad6c(TIL) \uc694\ubc95\uc758 \uc9c0\uc18d\uc801\uc778 \uc2b9\uc778 \ubaa8\uba58\ud140\uc5d0 \ud798\uc785\uc5b4 \uac00\uc7a5 \ud070 \ube44\uc911\uc744 \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uc720\uc804 \uc9c8\ud658 \ubd84\uc57c\ub294 14.36%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\uace0 \uc788\uc73c\uba70, \uacf5\uacf5 \uc790\uae08 \uc9c0\uc6d0\uacfc \uc131\uacf5\uc801\uc778 \uac04 \ud45c\uc801 AAV \uc784\uc0c1 \uc2dc\ud5d8\uc774 \uc131\uc7a5\uc744 \uacac\uc778\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc548\uacfc \ubd84\uc57c\ub294 \uc785\uc99d\ub41c \uc0c1\ud658 \uacbd\ub85c\uc640 \ub192\uc740 \uc784\uc0c1\uc801 \ud544\uc694\uc131\uc73c\ub85c \uc778\ud574 LUXTURNA\uc758 \uc804\ub2ec \uc6d0\ub9ac\ub97c \uc801\uc6a9\ud55c \ud6c4\uc18d \uc81c\ud488 \uac1c\ubc1c\uc774 \ud65c\ubc1c\ud569\ub2c8\ub2e4.<br \/>\n*   \ucd5c\uc885 \uc0ac\uc6a9\uc790: \ubc14\uc774\uc624 \uc81c\uc57d \ud601\uc2e0 \uae30\uc5c5\uc774 2025\ub144 \ub9e4\ucd9c\uc758 47.33%\ub97c \ucc28\uc9c0\ud588\uc9c0\ub9cc, CDMO\ub294 15.12%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\uc5ec \ucd5c\uc885 \uc0ac\uc6a9\uc790 \uae30\uc900\uc73c\ub85c \uac00\uc7a5 \ud070 \ub2e8\uc77c \ub9e4\ucd9c \ube44\uc911(52.67%)\uc744 \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub294 \uc720\uc804\uc790 \ubca1\ud130 \uc0b0\uc5c5 \uc804\ubc18\uc5d0 \uac78\uce5c \uc544\uc6c3\uc18c\uc2f1\uc758 \uc2ec\ud654\ub97c \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. \uc0bc\uc131 \ubc14\uc774\uc624\ub85c\uc9c1\uc2a4(Samsung Biologics)\uc758 \uc778\ucc9c \uc2e0\uaddc \ub2e8\uc9c0 \uac74\uc124\uacfc \ub860\uc790(Lonza)\uc758 \ub85c\uc288(Roche) \ubd80\uc9c0 \uc778\uc218\ub294 \uacf5\uae09\ub9dd \uc9c0\ubc30\ub97c \uc704\ud55c \uacbd\uc7c1\uc744 \uc2dc\uc0ac\ud569\ub2c8\ub2e4.<br \/>\n*   \uc0dd\uc0b0 \uc6cc\ud06c\ud50c\ub85c\uc6b0: \ud50c\ub77c\uc2a4\ubbf8\ub4dc \uc900\ube44, \uc138\ud3ec \ubc45\ud0b9, \ud615\uc9c8 \uac10\uc5fc\uc744 \ud3ec\ud568\ud558\ub294 \uc5c5\uc2a4\ud2b8\ub9bc(Upstream) \uacf5\uc815\uc740 2025\ub144 \ub9e4\ucd9c\uc758 62.05%\ub97c \ucc28\uc9c0\ud558\uba70 \uc720\uc804\uc790 \ubca1\ud130 \uc2dc\uc7a5\uc5d0\uc11c \uac00\uc7a5 \ud070 \ube44\uc911\uc744 \ucc28\uc9c0\ud569\ub2c8\ub2e4. \uc5c5\uc2a4\ud2b8\ub9bc \ub2e8\uacc4\uc5d0\uc11c\uc758 \uc218\uc728 \ucd5c\uc801\ud654\ub294 \ucd5c\uc885 \ube44\uc6a9\uc758 \uc8fc\uc694 \uacb0\uc815 \uc694\uc778\uc785\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \ub2e4\uc6b4\uc2a4\ud2b8\ub9bc(Downstream) \uc815\uc81c \ubc0f \ucda9\uc804-\ub9c8\uac10 \uacf5\uc815\uc740 13.25%\uc758 CAGR\ub85c \uc99d\uac00\ud558\uace0 \uc788\uc73c\uba70, \uc77c\ud68c\uc6a9 \ud06c\ub85c\ub9c8\ud1a0\uadf8\ub798\ud53c, \uc778\ub77c\uc778 \ubd84\uc11d, \uc5f0\uc18d \ud55c\uc678\uc5ec\uacfc \uae30\uc220\uc774 \uc8fc\ubaa9\ubc1b\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc9c0\uc5ed \ubd84\uc11d<\/p>\n<p>*   \ubd81\ubbf8 (2025\ub144 \ub9e4\ucd9c \uc810\uc720\uc728 38.12%): \uac15\ub825\ud55c \ubca4\ucc98 \uc790\uae08 \uc870\ub2ec, \uc219\ub828\ub41c \uc778\ub825, FDA\uc758 \uc2e0\uc18d \uc2ec\uc0ac \uacbd\ub85c \uc8fc\ub3c4\ub85c \uc2dc\uc7a5\uc744 \uc120\ub3c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. NIH\uc758 URGenT \ub124\ud2b8\uc6cc\ud06c\uc640 BGTC \ucee8\uc18c\uc2dc\uc5c4\uc740 \ud76c\uadc0 \uc9c8\ud658 \ubca1\ud130\uc5d0 \ub300\ud55c \uc9c0\uc6d0\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<br \/>\n*   \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 (CAGR 13.22%\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5): \uc784\uc0c1 \ubc0f \uc81c\uc870 \uc9c0\ud615\uc744 \uc7ac\ud3b8\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc911\uad6d\uc758 \ud575\uc0b0 \uc0dd\uc0b0 \ud5c8\ube0c \uc9c0\uc6d0 \uacc4\ud68d\uacfc \uc0bc\uc131 \ubc14\uc774\uc624\ub85c\uc9c1\uc2a4\uc758 \ud655\uc7a5\uc740 \ud55c\uad6d\uc774 \uc9c0\uc5ed CDMO \uc11c\ube44\uc2a4\ub97c \uc8fc\ub3c4\ud558\ub824\ub294 \uc57c\ub9dd\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. \uc544\uc2dc\uc544\ub294 \ud604\uc7ac \uc804 \uc138\uacc4 \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uc784\uc0c1 \uc2dc\ud5d8\uc758 48%\ub97c \ucc28\uc9c0\ud558\uba70, \uc11c\uad6c \uc9c0\uc5ed\uacfc \ub3d9\ub4f1\ud55c \uc218\uc900\uc785\ub2c8\ub2e4.<br \/>\n*   \uc720\ub7fd: \ud559\uc220 \uc5f0\uad6c \uac15\uad6d, \uc219\ub828\ub41c \uaddc\uc81c \uae30\uad00, \uc815\uad50\ud55c \uc0c1\ud658 \uc0dd\ud0dc\uacc4\ub97c \ud1b5\ud574 \uc911\uc694\ud55c \uae30\uc5ec\ub97c \ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub860\uc790\uc758 \uc2a4\uc704\uc2a4 \ubcf8\uc0ac\ub294 \uc774 \uc9c0\uc5ed\uc744 \uc9c0\uc18d\uc801\uc778 \uc81c\uc870 \uac70\uc810\uc73c\ub85c \uc790\ub9ac\ub9e4\uae40\ud558\uac8c \ud569\ub2c8\ub2e4.<br \/>\n*   \ub77c\ud2f4 \uc544\uba54\ub9ac\uce74 \ubc0f \uc911\ub3d9: \ube0c\ub77c\uc9c8\uc758 \uc784\uc0c1 \uc2dc\ud5d8 \uaddc\uc81c\uc640 \uc0ac\uc6b0\ub514\uc544\ub77c\ube44\uc544\uc758 \ubc14\uc774\uc624 \ud074\ub7ec\uc2a4\ud130 \uacc4\ud68d\uc744 \ud1b5\ud574 \uc810\uc9c4\uc801\uc778 \uc9c0\uc5ed \ucc38\uc5ec\uac00 \uc608\uc0c1\ub418\ub294 \ucd08\uae30 \ub2e8\uacc4\uc5d0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>\uc720\uc804\uc790 \ubca1\ud130 \uc2dc\uc7a5\uc740 \uc911\uac04 \uc815\ub3c4\uc758 \uc9d1\uc911\ub3c4\ub97c \ubcf4\uc774\uba70, \uc0c1\uc704 5\uac1c \uacf5\uae09\uc5c5\uccb4\uac00 2024\ub144 \ub9e4\ucd9c\uc758 \uc57d 35%\ub97c \ucc28\uc9c0\ud569\ub2c8\ub2e4. \ub178\ubcf4 \ud640\ub529\uc2a4\uc758 \uce74\ud0c8\ub80c\ud2b8 \uc778\uc218\ub294 \uac00\uc7a5 \ud070 CDMO \ubc1c\uc790\uad6d\uc744 \ub9cc\ub4e4\uc5c8\uc73c\uba70 \ubca1\ud130 \uacf5\uae09\uc5d0 \ub300\ud55c \uc9d1\uc911\ub3c4\ub97c \ub192\uc600\uc2b5\ub2c8\ub2e4. \uc368\ubaa8 \ud53c\uc154\uc758 \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uc0ac\uc5c5 \ucca0\uc218\ub294 \uc774 \ubd80\ubb38\uc758 \uc790\ubcf8 \uc9d1\uc57d\ub3c4\uc640 \uac00\uaca9 \uc555\ubc15\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4.<\/p>\n<p>REGENXBIO-\uc0ac\ub819\ud0c0 \uac04\uc758 AAV \uad8c\ub9ac \ubd84\uc7c1\uacfc \uac19\uc740 \ud2b9\ud5c8 \uc18c\uc1a1\uc740 \uc804\uc2e0 \uce58\ub8cc\uc81c\uc758 \ub77c\uc774\uc120\uc2a4 \uacbd\uc81c\ud559\uc744 \uc7ac\uc124\uc815\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4. \uc2dc\uc7a5 \uc120\ub450 \uc8fc\uc790\ub4e4\uc740 \uc218\uc9c1 \ud1b5\ud569\uc744 \ucd94\uad6c\ud558\uba70, \ud654\uc774\uc790\ub294 BEQVEZ \uac1c\ubc1c\uacfc \ub0b4\ubd80 \ubca1\ud130 \ub77c\uc778\uc744 \uacb0\ud569\ud588\uc9c0\ub9cc, \uc774\ud6c4 \ucd08\uae30 \uc790\uc0b0\uc744 \uc544\uc2a4\ud2b8\ub77c\uc81c\ub124\uce74(AstraZeneca)\uc5d0 10\uc5b5 \ub2ec\ub7ec\uc5d0 \ub9e4\uac01\ud558\uba70 \ucd08\uc810\uc758 \ubcc0\ud654\ub97c \ubcf4\uc5ec\uc8fc\uc5c8\uc2b5\ub2c8\ub2e4. \ubca1\ud130\ube4c\ub354(VectorBuilder) \ubc0f \uc81c\ub124\uc2a4\ud30c\uc774\uc5b4(Genespire)\uc640 \uac19\uc740 \uc2e0\ud765 \ud601\uc2e0 \uae30\uc5c5\ub4e4\uc740 \ud50c\ub7ab\ud3fc \ub2e4\uc6a9\uc131\uacfc \ub9cc\uc131\uc801\uc778 \uc0dd\uc0b0 \ub2a5\ub825 \uaca9\ucc28\ub97c \ubaa9\ud45c\ub85c \ud558\ub294 \uc790\uae08 \uc870\ub2ec \ub77c\uc6b4\ub4dc\uc5d0 \uc758\uc874\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc804\ub7b5\uc801 \uc81c\ud734\ub3c4 \ud655\uc0b0\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ucc30\uc2a4 \ub9ac\ubc84(Charles River)\uc640 \uac8c\uc774\uce20 \uc5f0\uad6c\uc18c(Gates Institute)\uc758 \ud30c\ud2b8\ub108\uc2ed\uc740 \uc18c\uc678 \uc5f4\ub300 \uc9c8\ud658 \ud30c\uc774\ud504\ub77c\uc778\uc744 \uc704\ud55c \uc804\uc6a9 \uc2ac\ub86f\uc744 \ud655\ubcf4\ud588\uc2b5\ub2c8\ub2e4. \uc720\ub2c8\ud050\uc5b4(UniQure)\ub294 \ub2e8\uc77c \uacf5\uae09\uc5c5\uccb4 \uc704\ud5d8\uc744 \ud5e4\uc9c0\ud558\uae30 \uc704\ud574 HEMGENIX \uacf5\uae09\uc744 \uc81c\ub124\uc820(Genezen)\uc5d0 \ub9e1\uacbc\uc73c\uba70, \uc774\ub294 \uc911\ubcf5 \uacf5\uae09\uc758 \uc911\uc694\uc131\uc744 \uac15\uc870\ud569\ub2c8\ub2e4. \uc804\ubc18\uc801\uc73c\ub85c \uc131\uacf5\uc740 GMP \uc804\ubb38\uc131, \uaddc\uc81c \uc2e0\ub8b0\uc131, \ud0c4\ub825\uc801\uc778 \uc18c\uc2f1 \ud504\ub808\uc784\uc6cc\ud06c\ub97c \uacb0\ud569\ud55c \uc870\uc9c1\uc73c\ub85c \uae30\uc6b8\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc0b0\uc5c5 \ub9ac\ub354: \uc368\ubaa8 \ud53c\uc154 \uc0ac\uc774\uc5b8\ud2f0\ud53d(Thermo Fisher Scientific, Inc.), \uba38\ud06c KGaA (\ubc00\ub9ac\ud3ec\uc5b4\uc2dc\uadf8\ub9c8, MilliporeSigma), \ub860\uc790 \uadf8\ub8f9(Lonza Group), \uce74\ud0c8\ub80c\ud2b8(Catalent Inc.), \uc625\uc2a4\ud3ec\ub4dc \ubc14\uc774\uc624\uba54\ub514\uce74(Oxford Biomedica).<\/p>\n<p>\ucd5c\uadfc \uc0b0\uc5c5 \ub3d9\ud5a5:<\/p>\n<p>*   2025\ub144 2\uc6d4: \ud654\uc774\uc790\uac00 \ud608\uc6b0\ubcd1 B \uce58\ub8cc\uc81c BEQVEZ\uc758 \uac1c\ubc1c\uc744 \uc911\ub2e8\ud558\uace0, \uc544\uc2a4\ud2b8\ub77c\uc81c\ub124\uce74\uac00 \uad00\ub828 \ubc1c\uacac \ud3ec\ud2b8\ud3f4\ub9ac\uc624\ub97c 10\uc5b5 \ub2ec\ub7ec\uc5d0 \uc778\uc218\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 1\uc6d4: FDA\ub294 \uc0ac\ub178\ud53c(Sanofi)\uc758 \uc820\uc790\uc784(Genzyme) \uacf5\uc7a5\uc5d0 CGMP(\uc6b0\uc218 \uc758\uc57d\ud488 \uc81c\uc870 \ubc0f \ud488\uc9c8 \uad00\ub9ac \uae30\uc900) \uc704\ubc18\uc73c\ub85c \uacbd\uace0 \uc11c\ud55c\uc744 \ubc1c\ud589\ud558\uba70 \uc624\uc5fc \uad00\ub9ac\uc758 \uc911\uc694\uc131\uc744 \uac15\uc870\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2024\ub144 12\uc6d4: \ub860\uc790\uac00 \ub85c\uc288\uc758 \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uc0dd\uc0b0 \uc2dc\uc124\uc744 12\uc5b5 \ub2ec\ub7ec\uc5d0 \uc778\uc218\ud558\uba70 \uc720\ub7fd \ub0b4 \uc0dd\uc0b0 \ub2a5\ub825\uc744 \ud655\uc7a5\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2024\ub144 11\uc6d4: \ub178\ubcf4 \ud640\ub529\uc2a4\uac00 \uce74\ud0c8\ub80c\ud2b8 \uc778\uc218\ub97c 165\uc5b5 \ub2ec\ub7ec\uc5d0 \uc644\ub8cc\ud558\uba70 \uc120\ub3c4\uc801\uc778 CDMO \ud50c\ub7ab\ud3fc\uc744 \uad6c\ucd95\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2024\ub144 10\uc6d4: \uc0bc\uc131 \ubc14\uc774\uc624\ub85c\uc9c1\uc2a4\uac00 \uc778\ucc9c\uc5d0 \uc0c8\ub85c\uc6b4 \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \ubcf5\ud569 \ub2e8\uc9c0 \uac74\uc124\uc5d0 14\uc5b5 6\ucc9c\ub9cc \ub2ec\ub7ec\ub97c \ud22c\uc790\ud558\uae30\ub85c \ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc720\uc804\uc790 \uce58\ub8cc\uc758 \ud575\uc2ec \uc694\uc18c\uc778 \uc720\uc804\uc790 \ubca1\ud130 \uc2dc\uc7a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc720\uc804\uc790 \uce58\ub8cc\ub294 \uc720\uc804 \ubb3c\uc9c8\uc744 \uc0ac\uc6a9\ud558\uc5ec \ud2b9\uc815 \uc9c8\ubcd1\uc744 \uce58\ub8cc\ud558\uac70\ub098 \uc608\ubc29\ud558\ub294 \uac83\uc744 \ubaa9\ud45c\ub85c \ud558\uba70, \uc720\uc804\uc801 \ubcc0\uc774\ub97c \uad50\uc815\ud558\uc5ec \uc2e0\uccb4 \ub0b4 \ud544\uc218 \ub2e8\ubc31\uc9c8\uc758 \uc815\uc0c1 \uae30\ub2a5\uc744 \ud68c\ubcf5\uc2dc\ud0a4\uace0 \uc804\ubc18\uc801\uc778 \uac74\uac15\uc744 \uc99d\uc9c4\ud558\ub294 \uac83\uc744 \ubaa9\uc801\uc73c\ub85c \ud569\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc804\ub9dd\uc5d0 \ub530\ub974\uba74, \uc720\uc804\uc790 \ubca1\ud130 \uc2dc\uc7a5\uc740 2026\ub144 21\uc5b5 2\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0\uc11c 2031\ub144\uae4c\uc9c0 37\uc5b5 9\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. 2025\ub144 \ub9e4\ucd9c\uc758 72.10%\ub97c \ucc28\uc9c0\ud558\uba70 \uc2dc\uc7a5\uc744 \uc9c0\ubc30\ud558\ub294 \uac83\uc740 \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uc2dc\uc2a4\ud15c\uc774\uba70, \uc774\ub294 \uad11\ubc94\uc704\ud55c \uc784\uc0c1 \uac80\uc99d\uc5d0 \uae30\uc778\ud569\ub2c8\ub2e4. CDMO(Contract Development &#038; Manufacturing Organizations)\ub294 2025\ub144 \ub9e4\ucd9c\uc758 52.67%\ub97c \ucc28\uc9c0\ud558\uba70 \uc2dc\uc7a5\uc5d0\uc11c \uc911\uc694\ud55c \uc5ed\ud560\uc744 \ud558\uace0 \uc788\ub294\ub370, \uc774\ub294 \uc758\uc57d\ud488 \uc2a4\ud3f0\uc11c\ub4e4\uc774 \ubcf5\uc7a1\ud55c \uc81c\uc870 \uacf5\uc815\uc744 \uaddc\ubaa8\uc640 \uaddc\uc81c \uc900\uc218 \uc804\ubb38\uc131\uc744 \uac16\ucd98 \uc804\ubb38 \uacf5\uae09\uc5c5\uccb4\uc5d0 \uc544\uc6c3\uc18c\uc2f1\ud558\ub294 \uacbd\ud5a5\uc774 \uc99d\uac00\ud558\uace0 \uc788\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4. \uc9c0\uc5ed\ubcc4\ub85c\ub294 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 13.22%\uc758 \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \uc774\ub294 \ub300\uaddc\ubaa8 \uc0dd\uc0b0 \ub2a5\ub825 \ud22c\uc790\uc640 \uc6b0\ud638\uc801\uc778 \uaddc\uc81c \uc815\ucc45\uc5d0 \ud798\uc785\uc740 \ubc14 \ud07d\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc131\uc7a5\uc758 \uc8fc\uc694 \ub3d9\ub825\uc73c\ub85c\ub294 \uc720\uc804\uc790 \uce58\ub8cc\uc81c \ud30c\uc774\ud504\ub77c\uc778\uc758 \ud655\uc7a5 \ubc0f \uc2b9\uc778 \uc99d\uac00, \uc804\ub7b5\uc801 \ud611\ub825 \ubc0f CDMO \uc0dd\uc0b0 \ub2a5\ub825 \ud655\uc7a5, \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uc0dd\uc0b0 \uae30\uc220\uc758 \ubc1c\uc804, \ube44\ubc14\uc774\ub7ec\uc2a4 \uc804\ub2ec \ud50c\ub7ab\ud3fc\uc5d0 \ub300\ud55c \ud22c\uc790 \uc99d\uac00, \ud76c\uadc0 \uc9c8\ud658 \uce58\ub8cc\ub97c \uc704\ud55c \uc815\ubd80 \uc790\uae08 \uc9c0\uc6d0, \uadf8\ub9ac\uace0 \uc0c8\ub85c\uc6b4 \ud604\uc7a5 \uc81c\uc870 \ubaa8\ub378\uc758 \ub4f1\uc7a5\uc774 \uc788\uc2b5\ub2c8\ub2e4. \ubc18\uba74, \ub192\uc740 \uc81c\uc870 \ube44\uc6a9\uacfc \uacf5\uc815 \ubcf5\uc7a1\uc131, \uc219\ub828\ub41c \uc778\ub825 \ubd80\uc871 \ubc0f \uad50\uc721 \uaca9\ucc28, \ud575\uc2ec \uc6d0\uc790\uc7ac \uacf5\uae09\ub9dd \uc81c\uc57d, \uadf8\ub9ac\uace0 \uc2e0\uaddc \ucea1\uc2dc\ub4dc(capsid) \uad00\ub828 \uc9c0\uc801 \uc7ac\uc0b0\uad8c \uc7a5\ubcbd\uc740 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4. \ud2b9\ud788, \ub192\uc740 \uc81c\uc870 \ube44\uc6a9\uacfc \uacf5\uc815 \ubcf5\uc7a1\uc131\uc740 \uc720\uc804\uc790 \uce58\ub8cc\uc758 \uad11\ubc94\uc704\ud55c \ucc44\ud0dd\uc5d0 \uac00\uc7a5 \ud070 \uc7a5\ubcbd\uc73c\ub85c \uc9c0\ubaa9\ub418\uba70, \uc774\ub294 \uc608\uce21 CAGR\uc5d0\uc11c \uc57d 1.2%\ud3ec\uc778\ud2b8\ub97c \uac10\uc18c\uc2dc\ud0a4\ub294 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4. \ubbf8\uad6d FDA\ub294 2025\ub144\ubd80\ud130 \ub9e4\ub144 10~20\uac74\uc758 \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uce58\ub8cc\uc81c \uc2b9\uc778\uc744 \uc608\uc0c1\ud558\uba70, \uc9c0\uc18d\uc801\uc778 \uaddc\uc81c \ubaa8\uba58\ud140\uc744 \uc2dc\uc0ac\ud569\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \ubca1\ud130 \uc720\ud615(\ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130: AAV, \ub80c\ud2f0\ubc14\uc774\ub7ec\uc2a4, \uc544\ub370\ub178\ubc14\uc774\ub7ec\uc2a4, \ub808\ud2b8\ub85c\ubc14\uc774\ub7ec\uc2a4, \ud5e4\ub974\ud398\uc2a4 \uc2ec\ud50c\ub809\uc2a4 \ubc14\uc774\ub7ec\uc2a4; \ube44\ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130: \ud50c\ub77c\uc2a4\ubbf8\ub4dc DNA, \uc9c0\uc9c8 \ub098\ub178\uc785\uc790(LNP), \uace0\ubd84\uc790 \uae30\ubc18 \ubca1\ud130, \ud558\uc774\ube0c\ub9ac\ub4dc \ubca1\ud130), \uc804\ub2ec \ubc29\uc2dd(\uc0dd\uccb4 \ub0b4(In-vivo), \uc0dd\uccb4 \uc678(Ex-vivo)), \uce58\ub8cc \ubd84\uc57c(\uc885\uc591\ud559, \uc720\uc804 \uc9c8\ud658, \uac10\uc5fc\uc131 \uc9c8\ud658, \uc2ec\ud608\uad00 \uc9c8\ud658, \uc548\uacfc, \uc2e0\uacbd \uc9c8\ud658 \ub4f1), \ucd5c\uc885 \uc0ac\uc6a9\uc790(\ubc14\uc774\uc624\uc81c\uc57d \ubc0f \uc0dd\uba85\uacf5\ud559 \uae30\uc5c5, CDMO, \ud559\uc220 \ubc0f \uc5f0\uad6c \uae30\uad00, \ubcd1\uc6d0 \ubc0f \ud074\ub9ac\ub2c9), \uc0dd\uc0b0 \uc6cc\ud06c\ud50c\ub85c\uc6b0(\uc5c5\uc2a4\ud2b8\ub9bc, \ub2e4\uc6b4\uc2a4\ud2b8\ub9bc), \uadf8\ub9ac\uace0 \uc9c0\uc5ed(\ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8)\ubcc4\ub85c \uc2dc\uc7a5\uc744 \uc138\ubd84\ud654\ud558\uc5ec \ubd84\uc11d\ud569\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd \ubd84\uc11d\uc5d0\uc11c\ub294 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4, \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d, \uadf8\ub9ac\uace0 Thermo Fisher Scientific, Merck KGaA, Lonza Group, Catalent Inc., Samsung Biologics \ub4f1 \uc8fc\uc694 \uae30\uc5c5\ub4e4\uc758 \ud504\ub85c\ud544(\uae00\ub85c\ubc8c \ubc0f \uc2dc\uc7a5 \uc218\uc900 \uac1c\uc694, \ud575\uc2ec \uc0ac\uc5c5 \ubd80\ubb38, \uc7ac\ubb34, \uc778\ub825, \uc8fc\uc694 \uc815\ubcf4, \uc2dc\uc7a5 \uc21c\uc704, \uc2dc\uc7a5 \uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ubd84\uc11d \ud3ec\ud568)\uc744 \ub2e4\ub8f9\ub2c8\ub2e4. \ud5a5\ud6c4 \uc2dc\uc7a5\uc740 \ubbf8\ucda9\uc871 \uc218\uc694(unmet need) \uc601\uc5ed\uacfc \uc0c8\ub85c\uc6b4 \uae30\ud68c\ub97c \ud1b5\ud574 \uc9c0\uc18d\uc801\uc778 \uc131\uc7a5\uc774 \uae30\ub300\ub429\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-35159","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/35159"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=35159"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/35159\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=35159"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=35159"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=35159"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}